You may laugh, and you may cry. But hopefully you'll feel a little less alone in your struggles after reading these ...
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and is around 1,000 prescriptions weekly by late January.